C399 - Campfire Session
IS and Viral Hepatitis

Monday July 02, 2018 | 16:30 to 17:30
Room: Hall 10 - Exhibition
Track: Liver


Dr. Tommaso Maria Manzia, Italy
Cost effectiveness of immunosuppression withdrawal after liver transplantation

Dr. Takehisa Ueno, Japan
Mycophenolate mofetil effect and trough level under 2-year old in pediatric living donor liver transplantation

Ms. Bettina Buchholz, United Kingdom
New insights from the SILVER study; a 50 % reduction in calcineurin inhibitors at day 30 achieves a temporary renal-sparing effect but does not impact on long-term renal function after liver transplantation.

Gabriel E. Gondolesi, Argentina
22 years of experience in hepatic re-transplantation: Value of predictive survival scores

Dr. Carmelo Loinaz, Spain
Long term nucleos(t)ide analog therapy after immunglobuline withdrawal in liver transplant recipients to prevent recurrent hepatitis B

Dr. Seung Wook Han, Korea
Phase 1/2a trial of a bioartificial liver support system (LifeLiver) for acute liver failure patients

© 2023 TTS2018